Azo compounds in colon-specific drug delivery

Marta Roldo, Eugen Barbu, James Brown, David Laight, John D. Smart, John Tsibouklis

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Azo compounds have the potential to act as drug carriers that facilitate the selective release of therapeutic agents to the colon, and also to effect the oral administration of those macromolecular drugs that require colon-specific drug delivery. With some further research-driven refinements, these materials may lead to more efficient treatments for local conditions, such as colonic cancer or inflammatory bowel disease. This article provides an overview of the azo-based systems developed to date, identifies the requirements for an ideal carrier, and highlights the directions for further developments in the field of azo group-facilitated colonic delivery.
    Original languageEnglish
    Pages (from-to)547-560
    Number of pages14
    JournalExpert Opinion on Drug Delivery
    Volume4
    Issue number5
    DOIs
    Publication statusPublished - Sept 2007

    Fingerprint

    Dive into the research topics of 'Azo compounds in colon-specific drug delivery'. Together they form a unique fingerprint.

    Cite this